PTLA
Dew,
Have your opinion changed on PTLA since Betrixaban is ready for lunch and Andexanet has high change of approval in mid 2018. Management is horrible but at end of day science prevails.
I am not expert but I am convinced each drugs will have 1B-2B peak sale. What do you think, is there any meat left on this stock :)
Please do your own due diligence. My post is for information only.